Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease

Nature Genetics

Volumn 32, Issue 2, 2002, Pages 237-244

  Carrasquillo, Minerva M ^a   McCallion, Andrew S ^a   Puffenberger, Erik G ^b   Kashuk, Carl S ^a   Nouri, Nassim ^c   Chakravarti, Aravinda ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CLINIC FOR SPECIAL CHILDREN   (United States)

^c Thermo Fisher Scientific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 10Q; CHROMOSOME 13Q; CHROMOSOME 16Q; EDNRB GENE; EPISTASIS; GENE; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; HIRSCHSPRUNG DISEASE; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RET GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 16; DROSOPHILA PROTEINS; EPISTASIS, GENETIC; GENETIC MARKERS; HIRSCHSPRUNG DISEASE; HUMANS; INTESTINE, LARGE; LINKAGE DISEQUILIBRIUM; LOD SCORE; MICE; MICROSATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN;

ANIMALIA;

EID: 0036788576     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng998     Document Type: Article

References (37)

1. Puffenberger, E.G. et al. Identity-by-descent and association mapping of a recessive gene for Hirschsprung disease on human chromosome 13q22. Hum. Mol. Genet. 3, 1217-1225 (1994).
2. Puffenberger, E.G. et al. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79, 1257-1266 (1994).
3. Badner, J.A., Sieber, W.K., Garver, K.L. & Chakravarti, A. A genetic study of Hirschsprung disease. Am. J. Hum. Genet. 46, 568-580 (1990).
4. Chakravarti, A. & Lyonnet, S. Hirschsprung disease. in The Metabolic and Molecular Bases of Inherited Disease 8th edn (eds Scriver, C.R., Beaudet, A.L., Valle, D., Sly, W.S., Childs, B., Kinzler, K. & Vogelstein, B.) 6231-6255 (McGraw-Hill, New York, 2001).
5. Amiel, J. et al. Large-scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with involvement of midline structures. Am. J. Hum. Genet. 69, 1370-1377 (2001).
6. Chakravarti, A. Endothelin receptor-mediated signaling in Hirschsprung disease. Hum. Mol. Genet. 5, 303-307 (1996).
7. Bergey, L.L. The early settlement of Waterloo Township, Ontario, Canada. Pa. Mennon. Herit. 15, 9-20 (1992).
8. Bolk, S. et al. A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc. Natl Acad. Sci. USA 97, 268-273 (2000).
9. Gabriel, S.B. et al. Segregation at three loci explains familial and population risk in Hirschsprung disease. Nat. Genet. 31, 89-93 (2002).
10. Takeuchi, T. et al. Expression of T-cadherin (CDH13, H-Cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells. J. Neurochem. 74, 1489-1497 (2000).
11. Borrello, M.G. et al. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase C gamma. Mol. Cell Biol. 16, 2151-2163 (1996).
12. Obermeier, A. et al. Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma. EMBO J. 13, 1585-1590 (1994).
13. Fitze, G., Schreiber, M., Kuhlisch, E., Schackert, H.K. & Roesner, D. Association of RET protooncogene codon 45 polymorphism with Hirschsprung disease. Am. J. Hum. Genet. 65, 1469-1473 (1999).
14. Borrego, S. et al. Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression. J. Med. Genet. 36, 771-774 (1999).
15. Borrego, S. et al. RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease. J. Med. Genet. 37, 572-578 (2000).
16. Lane, P.W. Association of megacolon with two recessive spotting genes in the mouse. J. Hered. 57, 181-183 (1966).
17. Shin, M.K., Russell, L.B. & Tilghman, S.M. Molecular characterization of four induced alleles at the Ednrb locus. Proc. Natl Acad. Sci. USA 94, 13105-13110 (1997).
18. Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F. & Pachnis, V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367, 380-383 (1994).
19. Webster, W. Aganglionic megacolon in piebald-lethal mice. Arch. Pathol. 97, 111-117 (1974).
20. Hosoda, K. et al. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79, 1267-1276 (1994).
21. Pachnis, V., Mankoo, B. & Costantini, F. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119, 1005-1017 (1993).
22. Nataf, V., Lecoin, L., Eichmann, A. & Le Douarin, N.M. Endothelin-B receptor is expressed by neural crest cells in the avian embryo. Proc. Natl Acad. Sci. USA 93, 9645-9650 (1996).
23. Leibl, M.A. et al. Expression of endothelin 3 by mesenchymal cells of embryonic mouse caecum. Gut 44, 246-252 (1999).
24. Bourne, H.R. Signal transduction. Team blue sees red. Nature 376, 727-729 (1995).
25. van Biesen, T. et al. Receptor-tyrosine-kinase- and G β γ-mediated MAP kinase activation by a common signalling pathway. Nature 376, 781-784 (1995).
26. Prenzel, N. et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402, 884-888 (1999).
27. Luttrell, L.M., Daaka, Y. & Lefkowitz, R.J. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr. Opin. Cell. Biol. 11, 177-183 (1999).
28. Auricchio, A. et al. Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease. Am. J. Hum. Genet. 64, 1216-1221 (1999).
29. Rhim, H. et al. Spatially restricted hypopigmentation associated with an Ednrbs-modifying locus on mouse chromosome 10. Genome Res. 10, 17-29 (2000).
30. Miller, S.A., Dykes, D.D. & Polesky, H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215 (1988).
31. Weissenbach, J. et al. A second-generation linkage map of the human genome. Nature 359, 794-801 (1992).
32. Ceccherini, I. et al. Identification of the Cys634→Tyr mutation of the RET protooncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis. J. Endocrinol. Invest. 17, 201-204 (1994).
33. Mulligan, L.M. et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363, 458-460 (1993).
34. Lairmore, T.C. et al. A 1.5-megabase yeast artificial chromosome contig from human chromosome 10q11.2 connecting three genetic loci (RET, D10S94, and D10S102) closely linked to the MEN2A locus. Proc. Natl Acad. Sci. USA 90, 492-496 (1993).
35. Kent, W.J. BLAT - the BLAST-like alignment tool. Genome Res. 12, 656-664 (2002).
36. Gordon, D., Abajian, C. & Green, P. Consed: a graphical tool for sequence finishing. Genome Res. 8, 195-202 (1998).
37. Andrew, S,D., Delhanty, P.J., Mulligan, L.M. & Robinson, B.G. Sp1 and Sp3 transactivate the RET proto-oncogene promoter. Gene 256, 283-291 (2000).